Skip to main content
Gemina Laboratories Ltd. logo

Gemina Laboratories Ltd. — Investor Relations & Filings

Ticker · GLAB ISIN · CA3686501071 LEI · 9845006E1B1D0E9T0F50 CSE Manufacturing
Open in API
Filings indexed 108 across all filing types
Latest filing 2026-02-17 Declaration of Voting R…
Country CA Canada
Listing CSE GLAB

About Gemina Laboratories Ltd.

https://www.geminalabs.com/

Gemina Laboratories Ltd. is a biotechnology company specializing in the research, development, and commercialization of in-vitro diagnostics (IVD) and biosensing technologies. The company designs, builds, and sells Point-of-Care (PoC) diagnostics products, with a primary focus on applications for respiratory diseases. Gemina Labs utilizes a proprietary, patented surface binding chemistry platform, described as transformative, which underpins its next-generation biosensing solutions. This breakthrough chemistry is intended to fundamentally advance the rapid IVD sector. The company also operates within the broader human wellness monitoring market.

Recent filings

Filing Released Lang Actions
Notice of meeting - English.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a press release titled 'VERSES Announces Results of Special Meeting'. It explicitly details the voting results from a special meeting of shareholders, specifically mentioning the ratification of share alterations and private placements. This falls directly under the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-02-17 English
News release - English.pdf
Board/Management Information Classification · 100% confidence The document is a news release announcing the departure of the current CEO and the appointment of a new CEO (Robert Greene) at Gemina Laboratories Ltd. This falls directly under the category of announcements regarding changes in senior management.
2025-11-07 English
Material change report - English.pdf
Regulatory Filings Classification · 78% confidence The document is a Canadian Form 51-102F3 “Material Change Report,” a formal regulatory filing disclosing a cancelled private placement and director resignations. It does not present full financial results, quarterly or annual reports, or investor presentation materials, nor is it solely focused on capital/financing or board changes. As a catch-all for this type of miscellaneous regulatory disclosure, it falls under Regulatory Filings (RNS).
2025-10-09 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings Classification · 83% confidence The document is an OSC Form 13-502F1 “Class 1 and Class 3B Reporting Issuers – Participation Fee” management certification. It is a regulatory compliance filing to the Ontario Securities Commission detailing quarterly market values and fees payable, not an annual or interim financial report, earnings release, or shareholder document. It does not present audited financial statements or an investor presentation, but rather a statutory fee calculation form – fitting the general Regulatory Filings category (RNS).
2025-07-07 English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings Classification · 85% confidence The document is Form 13-501F1, a statutory filing made to the Alberta Securities Commission detailing participation fees and market valuation – a regulatory submission rather than an earnings release, management announcement, or dividend notice. It does not present corporate financial results or strategy but fulfills a compliance requirement under securities regulations. This falls under general regulatory filings when no more specific category applies.
2025-07-07 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 85% confidence The document is Form 52-109FV2 “Venture Issuer Basic Certificate” signed by the CFO certifying the interim financial report and MD&A for the period ended April 30, 2025. It is not the interim financial statements or MD&A themselves (IR), nor is it an announcement of their publication (RPA). It is a statutory certification under Canadian NI 52-109, which does not fit any other specific category. Therefore, it falls into the fallback Regulatory Filings category (RNS).
2025-06-27 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.